(-)-Nebivolol
CAS: 118457-16-2
Ref. 3D-FN26170
1mg | 813,00 € | ||
2mg | 1.276,00 € | ||
5mg | 2.614,00 € | ||
10mg | 4.463,00 € | ||
500µg | 569,00 € |
Información del producto
- (a-S,a'S,2R,2'S)-a,a'-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol][2S-[2R*[R*[R*(S*)]]]]-a,a'-[Iminobi s(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol
- (1S,1'S)-2,2'-iminobis{1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]ethanol}
- (aS,a,2R,2)-a,a[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol]
- (aS,a’S,2R,2’S)-a,a’-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol]
- 2H-1-Benzopyran-2-methanol, α,α′-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-, (αS,α′S,2R,2′S)-
- 2H-1-Benzopyran-2-methanol, α,α′-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-, [2S-[2R*[R*[R*(S*)]]]]-
- Levonebivolol
- R-67145
- l-Nebivolol
Nebivolol is a beta-blocker that has vasodilatory properties. It has been shown to be effective in the treatment of patients with hypertension and heart failure, although it is not used as first-line therapy. Nebivolol is metabolized to its active form by esterases, primarily found in the liver, and is excreted unchanged in urine. The main effect of nebidovolol is reducing the workload on the heart by decreasing the force of contraction and increasing blood flow through peripheral vessels. This drug also inhibits adrenergic receptors, which may lead to a decrease in cardiac contractility.
Propiedades químicas
Consulta técnica sobre: 3D-FN26170 (-)-Nebivolol
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.